Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Hemophagocytic Lymphohistiocytosis: A Single Institution Experience

Poornima Ramadas, MBBS, Jennifer Leibovitch, MD, Teresa Gentile, MD PhD

Blood (2019) 134 (Supplement_1): 4877.

https://doi.org/10.1182/blood-2019-127517

Published: 2019

Journal Articles

ERG11 and ABC2 Overexpression but Not ERG11 Gene Mutations Are Involved in the Development of Itraconazole Resistance in Candida Krusei

Xiaoyuan He, Mingfeng Zhao, MDPhD, Jinyan Chen, Rimao Wu, PhD, Jianlei Zhang, Rui Cui, MDPhD, Yanyu Jiang, Jie Chen, Xiaoli Cao, Yi Xing, Juanxia Meng, Qi Deng, Tao Sui, MDPhD

Blood (2015) 126 (23): 4624.

https://doi.org/10.1182/blood.V126.23.4624.4624

Published: 2015

Journal Articles

The Identification and Use of a Three Fungus-Antigen Combination to Generate T-Cell Products with Activity Against Pathogenic Filamentous Fungi and Yeasts for Clinical Cell Therapy

Shiva Deo, BSc PhD, Balaji Virassamy, M. Biotech, Catriona Halliday, PhD, Leighton Edward Clancy, PhD, Wieland Meyer, PhD, Sharon Chen, MB BS FRACP FRCPA PhD, Tania Sorrell, MB BS PhDFRACP FRCPA, David Gottlieb, MB MDFRCPA FRACP

Blood (2014) 124 (21): 3839.

https://doi.org/10.1182/blood.V124.21.3839.3839

Published: 2014

Journal Articles

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Brian C. Shaffer, MD, Andrew Flynn, David Moorshead, Zach Powell, Jennifer Hsu, RN, Rachel B Salit, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael Bishop, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 4580.

https://doi.org/10.1182/blood.V122.21.4580.4580

Published: 2013

Journal Articles

Six Months Evaluation Of Pathogens and Drug Resistance In Blood Cultures From Hematoogy Patients With Febrile Neutropenia. Casablanca University Hospital Experience

Asmaa AQ Quessar, MD, Benzaid Hanane, PH, Hachmane Soukaina, Khoubila Nisrine, MD, El Kadiou Fatima, PH, Ouhadous Mohamed, Igala Marielle, MD, Benbachir Mohamed, PH, Zerouali Khalid, PHD

Blood (2013) 122 (21): 5622.

https://doi.org/10.1182/blood.V122.21.5622.5622

Published: 2013

Journal Articles

Higher Infused Cell Dose Is Associated with a Decreased Risk of Invasive Fungal Infections After Allogeneic Hematopoietic Stem Cell Transplantation

Aazim Kamal Omer, MD, Panayiotis D Ziakas, MD, PhD, Theodora Anagnostou, MD, Themistoklis Kourkoumpetis, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Eyal C. Attar, MD, Yi-Bin A. Chen, MD, Thomas R. Spitzer, MD, Eleftherios E Mylonakis, MD, Karen K. Ballen, MD

Blood (2012) 120 (21): 4134.

https://doi.org/10.1182/blood.V120.21.4134.4134

Published: 2012

Journal Articles

Clinical and Pharmacokinetic Evaluation of Prophylactic Micafungin 150mg Daily Against Invasive Fungal Infections in Cord Blood Transplant Recipients

Yuki Asano-Mori, MD, PhD, Hikari Ota, MD, Aya Nishida, MD, Taichi Ikebe, MD, PhD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Akiko Yoneyama, MD, PhD, Shigeyoshi Makino, MD, PhD, Satoshi Kishino, PhD, Shuichi Taniguchi, MD, PhD

Blood (2011) 118 (21): 1961.

https://doi.org/10.1182/blood.V118.21.1961.1961

Published: 2011

Journal Articles

Results of a Prospective Non-Randomized Trial Comparing the Efficacy of Voriconazole (Vor) and Posaconazole (Pos) As Primary Prophylactic Agents of Invasive Fungal Infections (IFI) in Acute Leukemic Patients

Mario Ojeda-Uribe, MD, Celine Haby, Alain Gravet, MD, Catherine Berg, PharmD, Olivier Aujoulat, PharmD, Eric Jeandidier, MD, Caroline Lohmann, MD, Bernard Drenou, MD, PhD, Benoît Lesquerbault, BSc

Blood (2011) 118 (21): 1120.

https://doi.org/10.1182/blood.V118.21.1120.1120

Published: 2011

Journal Articles

Combination Melphalan and Bortezomib Conditioning with Autologous Hematopoietic Stem Cell Support in Patients with Advanced Multiple Myeloma. A Phase I/II Study.

Scott D. Rowley, MD, FACP, David Siegel, MD, PhD, Michele L. Donato, MD, Andrew L. Pecora, MD, Tatyana Feldman, MD, Stuart Goldberg, MD, Andre Goy, MD, Aisha Masood, MD

Blood (2009) 114 (22): 1214.

https://doi.org/10.1182/blood.V114.22.1214.1214

Published: 2009

Journal Articles

Primary Prophylaxis against Invasive Fungal Infections (IFI) with Posaconazole (POS) or Voriconazole (VRC) Shows Better Efficacy Compared to No Systemic Prophylaxis during Induction and Consolidation Chemotherapy Cycles of Adult Acute Leukemia Patients

Mario E Ojeda Uribe, MD, Catherine Berg, Alain Gravet, Eric Sauleau, Dominique Bourderont, Celine Haby

Blood (2008) 112 (11): 4834.

https://doi.org/10.1182/blood.V112.11.4834.4834

Published: 2008

Journal Articles

Breakthrough Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation in Patients on Prophylactic Voriconazole.

Steve Trifilio, Seema Singhal, Stephanie Williams, Jane Winter, Martin Tallman, Leo Gordon, Olga Frankfurt, Andrew Evens, Jayesh Mehta

Blood (2006) 108 (11): 2849.

https://doi.org/10.1182/blood.V108.11.2849.2849

Published: 2006

NARROW

Hemophagocytic Lymphohistiocytosis: A Single Institution Experience

ERG11 and ABC2 Overexpression but Not ERG11 Gene Mutations Are Involved in the Development of Itraconazole Resistance in Candida Krusei

The Identification and Use of a Three Fungus-Antigen Combination to Generate T-Cell Products with Activity Against Pathogenic Filamentous Fungi and Yeasts for Clinical Cell Therapy

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Six Months Evaluation Of Pathogens and Drug Resistance In Blood Cultures From Hematoogy Patients With Febrile Neutropenia. Casablanca University Hospital Experience

Higher Infused Cell Dose Is Associated with a Decreased Risk of Invasive Fungal Infections After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical and Pharmacokinetic Evaluation of Prophylactic Micafungin 150mg Daily Against Invasive Fungal Infections in Cord Blood Transplant Recipients

Results of a Prospective Non-Randomized Trial Comparing the Efficacy of Voriconazole (Vor) and Posaconazole (Pos) As Primary Prophylactic Agents of Invasive Fungal Infections (IFI) in Acute Leukemic Patients

Combination Melphalan and Bortezomib Conditioning with Autologous Hematopoietic Stem Cell Support in Patients with Advanced Multiple Myeloma. A Phase I/II Study.

Primary Prophylaxis against Invasive Fungal Infections (IFI) with Posaconazole (POS) or Voriconazole (VRC) Shows Better Efficacy Compared to No Systemic Prophylaxis during Induction and Consolidation Chemotherapy Cycles of Adult Acute Leukemia Patients

Breakthrough Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation in Patients on Prophylactic Voriconazole.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only